ClinicalTrials.Veeva

Menu

Outcomes of Posterior Urethral Valve Fulguration

A

Assiut University

Status

Not yet enrolling

Conditions

Posterior Urethral Valve

Treatments

Procedure: Fulguration

Study type

Observational

Funder types

Other

Identifiers

NCT06867263
Posterior urthral valve

Details and patient eligibility

About

To evaluate the long-term outcome after fulguration of the posterior urethral valve.

Full description

Posterior Urethral Valves (PUV) are the most common cause of lower urinary tract obstruction. More severe forms are detected early in pregnancy (mainly type I), while other forms are usually discovered later in childhood when investigating lower urinary tract symptoms. Bladder dysfunction is common and is associated with urinary incontinence in about 55% (0%-72%). Despite the removal of the obstruction by urethral valve ablation, pathological changes in the urinary tract can occur with progressive bladder dysfunction, which can cause deterioration of the upper urinary tract as well. For this reason, all children with PUV require long-term follow-up, always until puberty. In many cases, the life-long current status is uncertain. The current literature lacks research on long-term outcomes.

Enrollment

35 estimated patients

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with fulguration of PUV since 1 year or more

Exclusion criteria

  • Patients with neurogenic bladder or meningocele or spina bifida .

Patients with renal parenchymal disease and inflammation not related to posterior urethral valve .

Diabetic patients .

Parental refusal .

Trial contacts and locations

0

Loading...

Central trial contact

Keroles Ashraf Soliman Eskaros Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems